| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |